As demand for CAR T therapies strain traditional manufacturing, Autolus Therapeutics has tapped Cellares to evaluate whether that company’s automated Cell Shuttle platform can support expanded ...
This robust institutional backing and financial strength have enabled CCIG to transcend traditional manufacturing, positioning itself as a vital orchestrator of the global EV supply chain. The ...
CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--LumaCyte, a leader in advanced cellular analysis and precision bioanalytics, proudly announces the launch of its groundbreaking cell therapy application for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results